Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles-mumps-rubella vaccine: implications for immunization programs
Abstract
A mass immunization campaign with a Urabe-containing measles-mumps-rubella vaccine was carried out in 1997 in the city of Salvador, northeastern Brazil, with a target population of children aged 1-11 years. There was an outbreak of aseptic meningitis following the mass campaign. Cases of aseptic meningitis were ascertained through data collected from the records of children admitted to the local referral hospital for infectious diseases between March and October of 1997, using previously defined eligibility criteria. Vaccination histories were obtained through home visits or telephone calls. Eighty-seven cases fulfilled the study criteria. Of those, 58 cases were diagnosed after the vaccination campaign. An elevated risk of aseptic meningitis was observed 3 weeks after Brazil's national vaccination day compared with the risk in the prevaccination period (relative risk = 14.3; 95% confidence interval: 7.9, 25.7). This result was confirmed by a case series analysis (relative risk = 30.4; 95% confidence interval: 11.5, 80.8). The estimated risk of aseptic meningitis was 1 in 14,000 doses. This study confirms a link between measles-mumps-rubella vaccination and aseptic meningitis. The authors discuss the implications of this for the organization and planning of mass immunization campaigns.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Dourado 2000, the incidence of aseptic meningitis hospitalisation was significantly higher during the fourth week following the start of the immunisation campaign compared with the 23 pre-immunisation weeks (15 cases, RR 11.90; 95% CI 6.38 to 22.19).
“fourth (15 cases RR 11.90; 95% CI 6.38 to 22.19)”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Dourado 2000
In Dourado 2000, the authors attributed 32 of the 37 aseptic meningitis cases with known vaccination status and date occurring during epidemiological weeks 36 to 39 to the Urabe-containing MMR vaccine Pluserix (one in about 14,000 doses).
“Authors attributed 32 of the 37 cases to be due to Urabe-containing MMR vaccine Pluserix (one in about 14,000 doses).”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Dourado 2000
In Dourado 2000, the incidence of aseptic meningitis hospitalisation was significantly higher during the fifth week following the start of the immunisation campaign compared with the 23 pre-immunisation weeks (nine cases, RR 7.14; 95% CI 3.38 to 15.08).
“fifth (nine cases, RR 7.14; 95% CI 3.38 to 15.08)”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Dourado 2000
In Dourado 2000, the incidence of aseptic meningitis hospitalisation was significantly higher during the sixth week following the start of the immunisation campaign compared with the 23 pre-immunisation weeks (four cases, RR 3.17; 95% CI 1.12 to 9.02).
“sixth (four cases, RR 3.17; 95% CI 1.12 to 9.02)”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Dourado 2000
In Dourado 2000, the incidence of aseptic meningitis hospitalisation was significantly higher during the third week following the start of the immunisation campaign compared with the 23 pre-immunisation weeks (18 cases, RR 14.28; 95% CI 7.93 to 25.71).
“The incidence of aseptic meningitis hospitalisation was significantly higher during the third (18 cases risk ratio (RR) 14.28; 95% CI 7.93 to 25.71)”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Dourado 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006 · see citing works
RetractedEpidemiologic Research: Principles and Quantitative Methods.
Mayer, L. S., Kleinbaum, D. G., Kupper, L. L., & Morgenstern, H. (1984) · Journal of the American Statistical Association · doi:10.2307/2288427 · Cited by 2,905 · see citing works
Schonberger, L. B., Bregman, D. J., SULLIVAN-BOLYAI, J. Z., Keenlyside, R. A., Ziegler, D. W., RETAILLIAU, H. F., EDDINS, D. L., & Bryan, J. A. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112795 · Cited by 784 · see citing works
Impact of anti-vaccine movements on pertussis control: the untold story
Gangarosa, E., Gałazka, A., Wolfe, C., Phillips, L., Miller, E., Chen, R., & Gangarosa, R. E. (1998) · The Lancet · doi:10.1016/s0140-6736(97)04334-1 · Cited by 749 · see citing works
Relative Incidence Estimation from Case Series for Vaccine Safety Evaluation
Farrington, P. (1995) · Biometrics · doi:10.2307/2533328 · Cited by 363 · see citing works
Mumps and mumps vaccine: A global review
Galazka, A. M., Robertson, S., & Kraigher, A. (1999) · The Indian Journal of Pediatrics · doi:10.1007/bf02727158 · Cited by 310 · see citing works
Sabrá, A., Bellanti, J. A., & Colon, A. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77837-5 · Cited by 281 · see citing works
Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK children
Miller, E., Farrington, P., Goldracre, M., Pugh, S., Colville, A., Flower, A. J. E., Nash, J., Macfarlane, L., & Tettmar, R. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)91069-x · Cited by 203 · see citing works
Vaccine adverse events: causal or coincidental?
Chen, R. T., & DeStefano, F. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78423-3 · Cited by 182 · see citing works
INDIVIDUAL VERSUS PUBLIC PRIORITIES IN THE DETERMINATION OF OPTIMAL VACCINATION POLICIES
Fine, P., & CLARKSON, J. A. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114471 · Cited by 178 · see citing works
Aseptic meningitis as a complication of mumps vaccination
Sugiura, A., & Yamada, A. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199103000-00008 · Cited by 127 · see citing works
Etiology and Mortality of Bacterial Meningitis in Northeastern Brazil
Bryan, J. P., de Silva, H. R., Tavares, A., Rocha, H., & Scheld, W. M. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.1.128 · Cited by 105 · see citing works
Surveillance of antibody to measles, mumps, and rubella by age.
Morgan-Capner, P., Wright, J., Miller, C. L., & Miller, E. (1988) · BMJ · doi:10.1136/bmj.297.6651.770 · Cited by 92 · see citing works
Miller, E. (1995) · Vaccine · doi:10.1016/0264-410x(94)00086-3 · Cited by 91 · see citing works
Boulianne, N., Serres, G. D., Ratnam, S., Ward, B. J., Joly, J. R., & Duval, B. (1995) · Vaccine · doi:10.1016/0264-410x(95)00098-l · Cited by 72 · see citing works
A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine
Fujinaga, T., Motegi, Y., Tamura, H., & Kuroume, T. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199103000-00007 · Cited by 64 · see citing works
Measles vaccination and Guillain-Barré syndrome
da Silveira, G. M., SALISBURY, D. M., & de Quadrós, C. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07408-9 · Cited by 64 · see citing works
Assessing the Efficacy of a Mixed Vaccination Strategy against Rubella in São Paulo, Brazil
Massad, E., Azevedo, R. S., Burattini, M. N., Zanetta, D. M. T., Coutinho, F. A. B., Yang, H. M., de Moraes, J. C., Pannuti, C. M., Souza, V. A. U. F., Silveira, A. S. B., et al. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.4.842 · Cited by 62 · see citing works
DIETZ, V. J., & Cutts, F. T. (1997) · International Journal of Health Services · doi:10.2190/qpcq-fbf8-6abx-2tb5 · Cited by 59 · see citing works
Mumps meningitis and measles, mumps, and rubella vaccine
Colville, A., & Pugh, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92322-7 · Cited by 47 · see citing works
Vaccine safety versus vaccine efficacy in mass immunisation programmes
Nokes, D. J., & Anderson, R. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92601-w · Cited by 42 · see citing works
Factors influencing childhood immunisation in an urban area of Brazil.
Barreto, T., & Rodrigues, L. C. (1992) · Journal of Epidemiology & Community Health · doi:10.1136/jech.46.4.357 · Cited by 42 · see citing works
Wassilak, S. G. F., Glasser, J. W., Chen, R. T., Hadler, S. C., & THE VACCINE SAFETY DAIALINK INVESTIGATORS (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44473.x · Cited by 41 · see citing works
Estimation of the Risk of Aseptic Meningitis Associated with Mumps Vaccination, France, 1991–1993
Rebière, I., & Galy-Eyraud, C. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.6.1223 · Cited by 22 · see citing works
Economic analysis of the vaccination strategies adopted in Brazil in 1982.
Ugá, D. (1988) · PubMed · Cited by 16 · see citing works
Vaccine Information Pamphlets Here, But Some Physicians React Strongly
Goldsmith, M. F. (1992) · JAMA · doi:10.1001/jama.1992.03480150011003 · Cited by 12 · see citing works
Measles vaccination and inflammatory bowel disease
Miller, E. J., Goldblatt, D., & Cutts, F. T. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78531-7 · Cited by 9 · see citing works
Vaccine information pamphlets here, but some physicians react strongly
Goldsmith, M. F. (1992) · JAMA · doi:10.1001/jama.267.15.2005 · Cited by 8 · see citing works
Inquiry explains neonatal deaths in Brazil
Csillag, C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78514-7 · Cited by 2 · see citing works
Brazil burdened with measles outbreak
Csillag, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63159-5 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Cunha S, Dourado I, Barreto ML, et al. Associac,3o entre meningite asseptica e uso da vacina triplice viral durante a campanha vacinal de 1997. (In Portuguese). Informe Epi- demiol SUS 1998;7:29-61.
- Furesz J, Hockin JC. A case of mumps meningitis: a post- immunization complication? Can Dis Wkly Rep 1987;13:155-7.
- Morris S. A desigualdade e a saiide publica. [Inequality and public health]. (Editorial). (In Portuguese). Rev Saiide Publica 1997;31:543^.
Cited by
Sorted by citations
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719 · see citing works
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub3 · Cited by 372 · see citing works
Schattner, A. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.005 · Cited by 256 · see citing works
Vaccines for measles, mumps, rubella, and varicella in children
Pietrantonj, C. D., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub4 · Cited by 197 · see citing works
Neurologic disorders after measles-mumps-rubella vaccination
Mäkelä, A., Nuorti, J. P., & Peltola, H. (2002) · PEDIATRICS · doi:10.1542/peds.110.5.957 · Cited by 183 · see citing works
Control without separate controls: evaluation of vaccine safety using case-only methods
Farrington, C. P. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.017 · Cited by 128 · see citing works
Ghebremichael‐Weldeselassie, Y., Whitaker, H., & Farrington, P. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811001531 · Cited by 128 · see citing works
Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine
Su, S., Chang, H.-L., & Chen, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051686 · Cited by 120 · see citing works
Tapiainen, T., Prevots, R., Izurieta, H. S., Abramson, J. S., Bilynsky, R., Bonhoeffer, J., Bonnet, M.-C., Galama, J. M. D., Gillard, P. H., Griot, M., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.058 · Cited by 111 · see citing works
Vaccines for measles, mumps and rubella in children
Demicheli, V., Jefferson, T., Rivetti, A., & Price, D. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub2 · Cited by 104 · see citing works
Vaccines for measles, mumps, rubella, and varicella in children
Pietrantonj, C. D., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub5 · Cited by 100 · see citing works
Folb, P. I., Bernatowska, E. A., Chen, R. E., Clemens, J. D., Dodoo, A. N. O., Ellenberg, S. S., Farrington, P., John, T., Lambert, P., MacDonald, N. E., et al. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.11.1926 · Cited by 89 · see citing works
Unintended events following immunization with MMR: a systematic review
Jefferson, T., Price, D., Demicheli, V., & Bianco, E. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00271-8 · Cited by 86 · see citing works
Mumps vaccine virus strains and aseptic meningitis
Bonnet, M.-C., Dutta, A., Weinberger, C., & Plotkin, S. A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.049 · Cited by 78 · see citing works
Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines?
Connell, A. R., Connell, J., Leahy, T. R., & Hassan, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02089 · Cited by 72 · see citing works
da Cunha, S. S., Rodrigues, L. C., Barreto, M. L., & Dourado, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00438-8 · Cited by 67 · see citing works
Self-citationVigilância de eventos adversos pós-vacinação e segurança de programas de imunização
Waldman, E. A., Luhm, K. R., Monteiro, S. A. M. G., & de Freitas, F. R. M. (2010) · Revista de Saúde Pública · doi:10.1590/s0034-89102011000100020 · Cited by 62 · see citing works
Measles, Mumps, Rubella Vaccine (Priorix???; GSK-MMR)
Wellington, K., & Goa, K. L. (2003) · Drugs · doi:10.2165/00003495-200363190-00012 · Cited by 62 · see citing works
da Silveira, C. M., Kmetzsch, C. I., Mohrdieck, R., Sperb, A. F., & Prevots, D. R. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.5.978 · Cited by 60 · see citing works
Monitoring the Safety of Vaccines
Ellenberg, S. S., & Braun, M. M. (2002) · Drug Safety · doi:10.2165/00002018-200225030-00001 · Cited by 57 · see citing works
Enhancing vaccine safety capacity globally: A lifecycle perspective
Chen, R. T., Shimabukuro, T. T., Martin, D., ZUBER, P. L. F., Weibel, D. M., & Sturkenboom, M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.073 · Cited by 53 · see citing works
Mumps Vaccines: Current Challenges and Future Prospects
Almansour, I. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01999 · Cited by 52 · see citing works
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Pietrantonj, C. D. (2013) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1948 · Cited by 51 · see citing works
Paternal Military Service and Risk for Childhood Leukemia in Offspring
Wen, W., Shu, X., Steinbuch, M., Severson, R. K., Reaman, G. H., Buckley, J. D., & Robison, L. L. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010198 · Cited by 49 · see citing works
Ki, M. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf167 · Cited by 48 · see citing works
An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines
dos Santos, B. A., Ranieri, T. M. S., Bercini, M. A., Schermann, M. T., Famer, S., Mohrdieck, R., Maraskin, T., & Wagner, M. B. (2002) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892002001000004 · Cited by 46 · see citing works
Correlation of Genetic Variability with Safety of Mumps Vaccine Urabe AM9 Strain
Amexis, G., Fineschi, N., & Chumakov, K. (2001) · Virology · doi:10.1006/viro.2001.1009 · Cited by 44 · see citing works
Emerging Challenges and Opportunities in Infectious Disease Epidemiology
Lewnard, J. A., & Reingold, A. L. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy264 · Cited by 41 · see citing works
Pérez-Vilar, S., Weibel, D. M., Sturkenboom, M., BLACK, S. B., Maure, C. G., Castro, J. L., Bravo‐Alcántara, P., Dodd, C. N., Romio, S., de Ridder, M. A. J., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.012 · Cited by 35 · see citing works
Avaliação do sistema brasileiro de vigilância de eventos adversos pós-vacinação
Monteiro, S. A. M. G., Takano, O. A., & Waldman, E. A. (2011) · Revista Brasileira de Epidemiologia · doi:10.1590/s1415-790x2011000300002 · Cited by 34 · see citing works
Madsen, K. M., & Vestergaard, M. (2004) · Drug Safety · doi:10.2165/00002018-200427120-00001 · Cited by 34 · see citing works
Surveillance of adverse effects following vaccination and safety of immunization programs.
Waldman, E. A., Luhm, K. R., Monteiro, S. A. M. G., & de Freitas, F. R. M. (2011) · Greater South Information System · doi:10.60692/sbk7j-wh349 · Cited by 34 · see citing works
Recombinant mumps virus as a cancer therapeutic agent
Ammayappan, A., Russell, S. J., & Federspiel, M. J. (2016) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2016.19 · Cited by 32 · see citing works
Uso de registro informatizado de imunização na vigilância de eventos adversos pós-vacina
Sato, A. P. S., Ferreira, V. L. D. R., Tauil, M. D. C., Rodrigues, L. C., Barros, M. B., Martineli, E., Costa, Â., Inenami, M., & Waldman, E. A. (2018) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2018052000295 · Cited by 31 · see citing works
Dubai Medical College students’ scores on the Beck Depression Inventory
Ahmadi, J., Kamel, M. E., Ahmed, M. G., Bayoumi, F. A., & Moneenum, A. A. (2008) · Iranian Red Crescent Medical Journal · Cited by 27 · see citing works
Close the gap for routine mumps vaccination in Japan
Kitano, T. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1765619 · Cited by 26 · see citing works
Monteiro, S. A. M. G., Takano, O. A., & Waldman, E. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.059 · Cited by 25 · see citing works
Reyes‐Leyva, J., Baños-Lara, M. D. R., Borraz-Argüello, M. T., Santos‐López, G., Rosas-Murrieta, N. H., Alvarado, G., Camacho, I. H., Vallejo‐Ruiz, V., & Tapia-Ramı́rez, J. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.11.011 · Cited by 24 · see citing works
Plotkin, S. A., & Rubin, S. A. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50024-6 · Cited by 24 · see citing works
Lai, L. Y. H., Arshad, F., Areia, C. M., Alshammari, T. M., Alghoul, H., Casajust, P., Li, X., Dawoud, D., Nyberg, F., Pratt, N. L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837632 · Cited by 23 · see citing works
Rubin, S. A., & Plotkin, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00007-0 · Cited by 22 · see citing works
Measles-Mumps-Rubella Vaccine in the Italian Armed Forces
D’Amelio, R., Biselli, R., Fascia, G., & Natalicchio, S. (2000) · JAMA · doi:10.1001/jama.284.16.2053 · Cited by 22 · see citing works
Santos‐López, G., Cruz, C., Pazos, N., Vallejo‐Ruiz, V., Reyes‐Leyva, J., & Tapia-Ramı́rez, J. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.06.031 · Cited by 21 · see citing works
Neurovirulence safety testing of mumps vaccines—Historical perspective and current status
Rubin, S. A., & Afzal, M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.005 · Cited by 20 · see citing works
Aluminium adjuvants used in vaccines
Djurisic, S., Jakobsen, J. C., Petersen, S. B., Kenfelt, M., Klingenberg, S. L., & Gluud, C. N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013086 · Cited by 20 · see citing works
Rubin, S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00039-0 · Cited by 20 · see citing works
Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein
Santos‐López, G., Scior, T., Borraz-Argüello, M. T., Vallejo‐Ruiz, V., Camacho, I. H., Tapia-Ramı́rez, J., & Reyes‐Leyva, J. (2009) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702009000100007 · Cited by 19 · see citing works
da Cunha, S. S., & Dourado, I. C. (2003) · Health Policy · doi:10.1016/j.healthpol.2003.07.008 · Cited by 19 · see citing works
Self-citationMuta, H., Nagai, T., Ito, Y., Ihara, T., & Nakayama, T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.068 · Cited by 18 · see citing works
Aluminium adjuvants used in vaccines versus placebo or no intervention
Djurisic, S., Jakobsen, J. C., Petersen, S. B., Kenfelt, M., & Gluud, C. N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012805 · Cited by 18 · see citing works
Self-controlled case series design in vaccine safety: a systematic review
Nie, X., Xu, L., Bai, Y., Liu, Z., Liu, Z., Farrington, P., & Zhan, S. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2020108 · Cited by 18 · see citing works
Feiterna‐Sperling, C., nnimann, R. B., Tischer, A., Stettler, P., Durrer, P., & Gaedicke, G. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000183746.92218.f9 · Cited by 16 · see citing works
Park, T., Ki, M., & Yi, S. (2004) · Statistics in Medicine · doi:10.1002/sim.1540 · Cited by 15 · see citing works
Eventos adversos pós-vacinais e resposta social
Martins, R. D. M., & Maia, M. D. L. (2003) · História Ciências Saúde-Manguinhos · doi:10.1590/s0104-59702003000500018 · Cited by 15 · see citing works
ASEPTIC MENINGITIS AND VIRAL MENINGITIS
Cherry, J. D., & Bronstein, D. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50046-7 · Cited by 14 · see citing works
Escolano, S., Hill, C., & Tubert‐Bitter, P. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt128 · Cited by 12 · see citing works
Ledogar, R. J., Fleming, J. R., & Andersson, N. (2009) · BMC International Health and Human Rights · doi:10.1186/1472-698x-9-s1-s6 · Cited by 11 · see citing works
Aseptic meningitis following AZD1222 COVID-19 vaccination
Zavari, A., Hamidabad, N. M., & Hassanzadeh, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.12.035 · Cited by 10 · see citing works
Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine
Lucena, R., Gomes, I., Nunes, L., da Cunha, S. S., Dourado, I. C., Teixeira, M. G., Góes, J., Cardoso, E., Rodrigues, B., Cardoso, A., et al. (2002) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892002001000006 · Cited by 10 · see citing works
Self-citationLIVE ATTENUATED VACCINES FOR THE IMMUNOPROPHYLAXIS
Shamsutdinova, O. A. (2017) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2017-2-107-116 · Cited by 9 · see citing works
dos Santos, E. M., Sá, G. R. D. S. E., Siqueira, M. M., Martins, R. D. M., Camacho, L. A. B., von Doellinger, V. D. R., & Maia, M. D. L. D. S. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276130351 · Cited by 8 · see citing works
Enhancing Vaccine Safety Capacity Globally
Chen, R. T., Shimabukuro, T. T., Martin, D., ZUBER, P. L. F., Weibel, D. M., & Sturkenboom, M. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.09.009 · Cited by 8 · see citing works
The role of non-human primates in the neurological safety of live viral vaccines (review)
Levenbook, I. S. (2010) · Biologicals · doi:10.1016/j.biologicals.2010.11.003 · Cited by 8 · see citing works
Rosas-Murrieta, N. H., Camacho, I. H., Vallejo‐Ruiz, V., Millán-Pérez-Peña, L., Cruz, C., Tapia-Ramı́rez, J., Santos‐López, G., & Reyes‐Leyva, J. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.03.005 · Cited by 8 · see citing works
Nascimento-Carvalho, C. M., & Moreno-Carvalho, O. A. (2003) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2003000500005 · Cited by 7 · see citing works
Pharmacoepidemiologic Studies of Vaccine Safety
Chen, R. T., Glanz, J. M., & Vellozzi, C. J. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch26 · Cited by 6 · see citing works
Sahra, S., Jahangir, A., Glaser, A., Mobarakai, N. K., & Jahangir, A. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06453-5 · Cited by 5 · see citing works
Tratamento da Fase Aguda do Acidente Vascular Cerebral
de Neurologia, A. B. (2002) · Cited by 5 · see citing works
Gallagher, K. M., Plotkin, S. A., Katz, S. L., & Orenstein, W. A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1108-7_13 · Cited by 3 · see citing works
Miller, E., & Stowe, J. (2011) · Wiley eBooks · doi:10.1002/9780470975053.ch13 · Cited by 3 · see citing works
Gnann, J. W. (2009) · Wiley eBooks · doi:10.1128/9781555815981.ch38 · Cited by 3 · see citing works
Neurological Disorders Associated with Measles-Mumps-Rubella Vaccination- a Review
Batra, N. (2015) · Science Journal of Public Health · doi:10.11648/j.sjph.20150301.24 · Cited by 2 · see citing works
Rodríguez‐Pintó, I., & Shoenfeld, Y. (2015) · Wiley eBooks · doi:10.1002/9781118663721.ch37 · Cited by 2 · see citing works
Rubin, S. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00041-4 · Cited by 1 · see citing works
Aseptic Meningitis and Viral Meningitis
Bronstein, D. E., & Glaser, C. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00035-2 · Cited by 1 · see citing works
PRODUÇÃO DE CEPAS VACINAIS DO VÍRUS DA CAXUMBA: UMA REVISÃO DE LITERATURA
da Silva, A. D., & Matter, L. B. (2020) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v32.e1.a2020.pp6-12 · Cited by 1 · see citing works
Shahkarami, M. K., Azad, T. M., Aghaiypour, K., Shafyi, A., Taqavian, M., & Mohammadi, A. (2012) · Europe PMC (PubMed Central) · Cited by 1 · see citing works
Immunoprophylaxis of Viral Diseases
Hadler, S. C., & Seward, J. F. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0273 · Cited by 1 · see citing works
Studies on the Association of Meningitis and Mumps Virus Vaccination
Lara-Sampablo, A., Rosas-Murrieta, N. H., Camacho, I. H., Vallejo‐Ruiz, V., Santos-Lpez, G., & Reyes‐Leyva, J. (2012) · InTech eBooks · doi:10.5772/30892
Statistical Issues in Vaccine Safety Evaluation
Musonda, P. (2012) · Wiley eBooks · doi:10.1002/9781119940012.ch17
Silva, D. F. (2013) · Revista Baiana Saúde Pública · doi:10.22278/2318-2660.2013.v37.n0.a596
MESTRADO PROFISSIONAL EM VIGILÂNCIA EM SAÚDE
de Saúde, E. N., & Arouca, S. (2005)
Athiany, H., Wanjoya, A., Orwa, G. O., & Mwalili, S. M. (2020) · International Journal of Data Science and Analysis · doi:10.11648/j.ijdsa.20200606.12
Vaccine Epidemiology: Observational Vaccine Safety Study Designs
Hekimoğlu, C. H. (2021) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2021.29567
Functional effects of mutations in mumps virus polymerase protein
Nasheri, N. (2008) · PubMed · doi:10.20381/ruor-18870
Gnann, J. W., & Latner, D. R. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch39
Measles, mumps, and rubella vaccines
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00541-6
Ettinger, A. B., Weisbrot, D. M., & Gallimore, C. E. (2019) · Cambridge University Press eBooks · doi:10.1017/9781107706866.013
Wharton, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012373960-5.00590-6
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53272-5.50009-1
Dittmann, S. (2002) · Side effects of drugs annual · doi:10.1016/s0378-6080(02)80039-3
Block, F. (2006) · Springer eBooks · doi:10.1007/3-540-28604-7_9
Measles, mumps, and rubella vaccines
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01021-0
Sauder, C. J., Link, M. A., Ngo, L., Zhang, C., Chou, C., Wu, W. W., Zagorodnyaya, T. A., Laassri, M., & Rubin, S. A. (2026) · Vaccines · doi:10.3390/vaccines14090774
- Authors
- Dourado, I., Cunha, S., Teixeira, M. D. G., Farrington, C. P., Melo, A., Lucena, R., & Barreto, M. L.
- Affiliations
- Universidade Federal da Bahia (BR)
- Corresponding author
- Dourado, I.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-03-01
- Volume
- 151
- Issue
- 5
- Pages
- 524-530
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2131566531
- Cited by
- 95
- References
- 30
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 5 · 2020: 7 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 1 · 2013: 4 · 2012: 5
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Open Research Online (The Open University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- aseptic meningitis, MMR vaccine, mass vaccination campaigns, vaccine adverse events, immunization program planning, children, Salvador, Bahia
- MeSH terms
- Brazil, Child, Child, Preschool, Disease Outbreaks, Humans, Infant, Measles Vaccine, Meningitis, Aseptic, Mumps Vaccine, Mumps virus, Product Surveillance, Postmarketing, Retrospective Studies, Risk Factors, Rubella Vaccine, Urban Population, Vaccination, Incidence, Vaccines, Combined, Measles-Mumps-Rubella Vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review